Joel Erblich, PhD
- LECTURER | Population Health Science and Policy
- LECTURER | Oncological Sciences
Dr. Erblich is a behavioral health scientist experienced in cancer prevention and control, with an emphasis on nicotine and alcohol dependence. He received a PhD in clinical psychology from the University of Southern California, completed a clinical internship at UCLA, and completed postdoctoral fellowships in biobehavioral medicine at both the Memorial-Sloan Kettering Cancer Center and Mount Sinai. He has been a PI on numerous research grants and career development awards from diverse funding agencies, including the NCI, NIDA, American Cancer Society, Department of Defense Breast Cancer Research Program, PCORI, and others. In addition, Dr. Erblich was involved, and continues to be involved, in numerous multidisciplinary training and education grants, as well as several educational grants aimed at disseminating evidence-based behavioral interventions to manage cancer treatment side effects. Finally, because of his experience in biostatistics, Dr. Erblich currently serves as the methodologist on several R01 grants relating to behavioral medicine. Dr. Erblich is also a licensed psychologist in New York and New Jersey.
Addiction, Behavioral Health, Biostatistics, Cancer
Dr. Erblich's research focuses on the interactions among emotional, cognitive, behavioral and genetic factors in cancer prevention and control. Current efforts focus on nicotine dependence and alcoholism. Dr. Erblich's research takes a multidisciplinary-translational approach, with hypotheses driven by both the human and animal literatures that have contributed to the current understanding of motivations for drug use. The overall goal of Dr. Erblich's research in this area is to better understand how cognitive-behavioral, affective, and genetic factors impact smoking behavior. The research thus draws upon behavioral principles, such as personality, conditioning, and stress reactivity, as well as molecular biological principles, including genetic and cellular mechanisms of dopamine transmission to better understand motivation for substance use. Dr. Erblich is also a trained biostatistician and collaborates on a diverse portfolio of NIH-funded projects in cancer prevention and control, as well as projects that focus on the intergation of behavior and health more broadly.